Research summary, original research, 2018

Patient And Operating Room Staff Radiation Dose During Fenestrated/Branched Endovascular Aneurysm Repair Using Premanufactured Devices

Kirkwood ML, Chamseddin K, Arbique GM, Guild JB, Timaran D, Anderson JA, et al.. Journal of vascular surgery. 2018

Read the original paper

In plain language

In 80 fenestrated aortic repairs by one surgeon, real-time dosimetry showed lower doses to the surgeon, trainee and nurses with standard fenestrated and off-the-shelf devices than with custom-made devices, and higher operator dose with four-vessel repairs.

At a glance

Type of study
Original research, Prospective cohort study
Who was studied
Vascular surgeons, Trainees, Anesthesia staff, Nurses, Patients
Size
n = 80 procedures
Summary based on
the abstract

What it found

  • Zenith Fenestrated devices had lower patient and staff doses than custom-made devices.

    Key figures: operator 120 μSv vs 370 μSv; P = .004; patient 1800 mGy vs 2950 mGy; P = .004

  • Off-the-shelf branched devices had lower operator, assistant and circulator doses than custom-made devices.

    Key figures: operator 220 μSv vs 370 μSv; P = .04; circulator 4 μSv vs 30 μSv; P = .001

  • Four-vessel fenestrated repairs gave higher operator dose than three-vessel repairs.

    Key figures: 440 μSv vs 170 μSv; P = .0005

  • Nurse doses were much lower than operator and assistant doses.

    Key figures: circulator 10 μSv vs 30 μSv; scrub 10 μSv vs 40 μSv

  • Authors judged all doses within acceptable limits and lower than previously reported.

Limits to keep in mind

Single-center, single-surgeon series on one fluoroscopy system with dose-reduction technology, with small numbers in the ZFen and OTS groups and no adjustment beyond body mass index (BMI); device groups were not randomized.

How this summary was made

ORSIF prepared this summary with AI assistance from the abstract of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.

Prepared November 3, 2026.